3 Absurdly Cheap Dividend Stocks to Buy Before August |

When it comes to high-yield dividend stocks, it’s not a matter of quantity, but of quality.…

Airbnb Is in the Spotlight for All the Right Reasons. Here's Why It's a Buy Now. |

Airbnb (ABNB +4.08%) is a leading enterprise that was propelled by the mobile internet wave. Consequently,…

Teva's Turnaround Is Working. Here's the 1 Thing That Could Send It Soaring Another 50%. |

Year to date, Teva Pharmaceutical Industries (TEVA +0.94%) shares have continued to recover. Thanks to the…

Buy These 2 Boring Industrial Infrastructure Stocks This Month |

It’s pretty much impossible for investors not to have noticed that technology stocks — and artificial…

How to Make the Most of a 3.9% Social Security COLA Bump for 2027 |

We’re only three months away from October, the month when Social Security cost-of-living adjustments (COLAs) for…

This Unsung Artificial Intelligence (AI) Hero Just Announced Incredible News. Is It Still a Buy? |

There are countless companies involved in the AI build-out, and a few of them fly under…

Why Is Walt Disney Stock So Much Cheaper Than Netflix? This Is the Only Answer I Can Think Of. |

Walt Disney (DIS +2.18%) shares have tumbled. They now trade 52% below their record from March…

I'm Officially Sounding the Alarm on GE Vernova: Here's What Investors Should Buy Instead |

Let me be clear up front: GE Vernova (GEV -1.59%) is a terrific business. Its power-generation…

The Smartest Way to Invest $5,000 in a Trillion-Dollar Stock Over Private Space Plays |

Space is one of the most exciting investing themes going, but the ways to play it…

Cathie Wood's $362 Million CRISPR Therapeutics Bet Isn't Just Bold — It's Backed by a Catalyst Many Investors Are Underrating |

If you’re keeping an eye on gene-editing specialist CRISPR Therapeutics (CRSP -2.08%), you probably already know…

en_USEnglish (United States)